Expression of Nociceptive Ligands in Canine Osteosarcoma
Open Access
- 1 January 2015
- journal article
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 29 (1) , 268-275
Abstract
Background: Canine osteosarcoma (OS) is associated with localized pain as a result of tissue injury from tumor infiltration and peritumoral inflammation. Malignant bone pain is caused by stimulation of peripheral pain receptors, termed nociceptors, which reside in the localized tumor microenvironment, including the periosteal and intramedullary bone cavities. Several nociceptive ligands have been determined to participate directly or indirectly in generating bone pain associated with diverse skeletal abnormalities. Hypothesis: Canine OS cells actively produce nociceptive ligands with the capacity to directly or indirectly activate peripheral pain receptors residing in the bone tumor microenvironment. Animals: Ten dogs with appendicular OS. Methods: Expression of nerve growth factor, endothelin-1, and microsomal prostaglandin E synthase-1 was characterized in OS cell lines and naturally occurring OS samples. In 10 dogs with OS, circulating concentrations of nociceptive ligands were quantified and correlated with subjective pain scores and tumor volume in patients treated with standardized palliative therapies. Results: Canine OS cells express and secrete nerve growth factor, endothelin-1, and prostaglandin E2. Naturally occurring OS samples uniformly express nociceptive ligands. In a subset of OS-bearing dogs, circulating nociceptive ligand concentrations were detectable but failed to correlate with pain status. Localized foci of nerve terminal proliferation were identified in a minority of primary bone tumor samples. Conclusions and Clinical Importance: Canine OS cells express nociceptive ligands, potentially permitting active participation of OS cells in the generation of malignant bone pain. Specific inhibitors of nociceptive ligand signaling pathways might improve pain control in dogs with OS.Keywords
This publication has 37 references indexed in Scilit:
- Association between Absolute Tumor Burden and Serum Bone-Specific Alkaline Phosphatase in Canine Appendicular OsteosarcomaJournal of Veterinary Internal Medicine, 2013
- Effects of Different Electroacupuncture Scheduling Regimens on Murine Bone Tumor-Induced Hyperalgesia: Sex Differences and Role of InflammationEvidence-Based Complementary and Alternative Medicine, 2012
- Increased Urine and Serum Nerve Growth Factor Levels in Interstitial Cystitis Suggest Chronic Inflammation Is Involved in the Pathogenesis of DiseasePLOS ONE, 2012
- Human temporomandibular joint and myofascial pain biochemical profiles: a case‐control studyJournal of Oral Rehabilitation, 2012
- Microsomal prostaglandin E synthase-1 enhances bone cancer growth and bone cancer-related pain behaviors in miceLife Sciences, 2011
- Nerve growth factor concentrations in the synovial fluid from healthy dogs and dogs with secondary osteoarthritisVeterinary and Comparative Orthopaedics and Traumatology, 2011
- Blockade of nerve sprouting and neuroma formation markedly attenuates the development of late stage cancer painNeuroscience, 2010
- Pathological Sprouting of Adult Nociceptors in Chronic Prostate Cancer-Induced Bone PainJournal of Neuroscience, 2010
- Transient receptor potential vanilloid 4Annals of the New York Academy of Sciences, 2010
- Administration of a Tropomyosin Receptor Kinase Inhibitor Attenuates Sarcoma-Induced Nerve Sprouting, Neuroma Formation and Bone Cancer PainMolecular Pain, 2010